0001209191-23-047102.txt : 20230823 0001209191-23-047102.hdr.sgml : 20230823 20230823175622 ACCESSION NUMBER: 0001209191-23-047102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230821 FILED AS OF DATE: 20230823 DATE AS OF CHANGE: 20230823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fordyce Marshall CENTRAL INDEX KEY: 0001859453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 231198490 MAIL ADDRESS: STREET 1: C/O VERA THERAPEUTICS, INC. STREET 2: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-21 0 0001831828 Vera Therapeutics, Inc. VERA 0001859453 Fordyce Marshall C/O VERA THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 1 1 0 0 President and CEO 1 Class A Common Stock 2023-08-21 4 S 0 5210 16.6562 D 243361 D Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on August 26, 2022. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.893, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Includes shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022 for 1,085 shares, and on March 13, 2023 for 1,183 shares. /s/ Joseph R. Young, Attorney-in-Fact 2023-08-23